CGL
IDXX icon

Clarius Group LLC’s Idexx Laboratories IDXX Stock Holding History

Clarius Group LLC’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$773K Buy
1,143
+721
+171% +$491K 0.04% 150
2025
Q3 		$270K Sell
422
-243
-37% -$147K 0.02% 330
2025
Q2 		$357K Sell
665
-116
-15% -$55.5K 0.02% 314
2025
Q1 		$328K Buy
781
+69
+10% +$30K 0.02% 333
2024
Q4 		$294K Sell
712
-53
-7% -$23.2K 0.02% 327
2024
Q3 		$386K Sell
765
-68
-8% -$33K 0.03% 262
2024
Q2 		$406K Sell
833
-3
-0.4% -$1.51K 0.03% 248
2024
Q1 		$451K Sell
836
-79
-9% -$43.2K 0.03% 240
2023
Q4 		$508K Sell
915
-73
-7% -$34.3K 0.04% 232
2023
Q3 		$432K Sell
988
-299
-23% -$149K 0.04% 247
2023
Q2 		$646K Sell
1,287
-20
-2% -$9.58K 0.05% 209
2023
Q1 		$654K Sell
1,307
-31
-2% -$14.8K 0.06% 196
2022
Q4 		$546K Buy
1,338
+100
+8% +$38.8K 0.05% 233
2022
Q3 		$403K Buy
1,238
+19
+2% +$6.98K 0.04% 265
2022
Q2 		$428K Buy
1,219
+125
+11% +$51K 0.04% 247
2022
Q1 		$720K Hold
1,094
– – 0.06% 178
2021
Q4 		$720K Buy
1,094
+14
+1% +$8.79K 0.06% 178
2021
Q3 		$672K Buy
1,080
+1
+0.1% +$672 0.06% 170
2021
Q2 		$681K Buy
1,079
+14
+1% +$7.73K 0.06% 163
2021
Q1 		$521K Sell
1,065
-112
-10% -$56.1K 0.05% 183
2020
Q4 		$588K Buy
1,177
+163
+16% +$72.9K 0.06% 151
2020
Q3 		$399K Buy
1,014
+28
+3% +$10.4K 0.05% 172
2020
Q2 		$326K Buy
986
+39
+4% +$11.3K 0.05% 202
2020
Q1 		$229K Buy
947
+77
+9% +$20.1K 0.04% 222
2019
Q4 		$251K Sell
870
-79
-8% -$20.8K 0.04% 242
2019
Q3 		$258K Buy
949
+69
+8% +$19.2K 0.05% 219
2019
Q2 		$242K Buy
+880
New +$217K 0.05% 207

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSC
J. Stern & Co London, United Kingdom $1.03B AUM 20.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clarius Group LLC's IDXX Position: Q4 2025 in Review

Clarius Group LLC increased its Idexx Laboratories (IDXX) stake by 171% in Q4 2025, buying an estimated $491K and bringing the position to 1,143 shares worth $773K. The position accounts for 0.04% of the portfolio, ranked #150.

Clarius Group LLC first reported a position in IDXX in Q2 2019 and has held it in 27 quarters since. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

  • Clarius Group LLC held 1,143 shares of Idexx Laboratories worth $773K as of Q4 2025.
  • Clarius Group LLC bought 721 Idexx Laboratories shares in Q4 2025, an estimated $491K.
  • Idexx Laboratories made up 0.04% of Clarius Group LLC's portfolio in Q4 2025, its #150 holding.
  • Clarius Group LLC first reported a position in Idexx Laboratories in Q2 2019 and has held it in 27 quarters since.
  • 1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Clarius Group LLC's 13F filing for Q4 2025, filed 14 Jan 2026.